Global Cardiac Valve Repair Devices Market

Global Cardiac Valve Repair Devices Market Size Insights Forecasts to 2035

• Global Cardiac Valve Repair Devices Market Size Is Expected to Grow at a CAGR of Around 8.9% from 2025 to 2035.
• Global Cardiac Valve Repair Devices Market Size Is Expected to Reach a Significant Share by 2035     
• Asia-Pacific is expected to Grow the fastest during the forecast period.

According to a Research Report Published by Decisions Advisors and Consulting, The Global Cardiac Valve Repair Devices Market Size is expected to hold a significant share by 2035, at a CAGR of 8.9% during the forecast period 2025-2035. The upcoming prospects in the worldwide cardiac valve repair devices industry are presented through the development of new minimally invasive technologies, the provision of transcatheter repair solutions, the increase in the number of elderly people, the opening of new markets, the policies on reimbursement being made more favorable, and the research in imaging and biomaterials technology being the main reason for their more widespread use.

 

Market Overview

The global cardiac valve repair devices market consists of repairing medical devices or reconstructing the heart valves that were damaged, thereby improving cardiac functioning and patient’s lives while cutting down the complications of valvular heart diseases. Among these devices are solutions for mitral, aortic, pulmonary, and tricuspid valve repair delivered by various means: open-heart surgery, minimally invasive procedures, or even through transcatheter interventions like TAVR and TMVR. The market is expanding due to increasing cardiovascular diseases, new technologies in the design of the devices, and growing acceptance of less invasive procedures. Besides, the governments in North America and Europe through their enabling policies and reimbursement schemes for the healthcare sector are indirectly contributing to the market expansion by funding the advanced cardiac care, making early diagnosis easier, and allowing access to the new valve repair technologies. Moreover, the developing countries are also receiving the investments in their healthcare infrastructures which in turn is leading to the further increase in the market size.

 

Report Coverage

This research report categorizes the cardiac valve repair devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the cardiac valve repair devices market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the cardiac valve repair devices market. 

 

Driving Factors

The global cardiac valve repair devices market is composed of medical devices that are used to treat heart valve failures through the repair or reconstruction of the damaged valves, which in turn improves the function of the heart and reduces the risk of complications. The expansion of the market is mainly due to the increasing number of people suffering from cardiovascular diseases, better technologies in the area of minimally invasive and transcatheter procedures, the rise in the elderly population, and the development of healthcare infrastructure across the world.

 

Restraining Factors

The market for global cardiac valve repair devices is bound by several restraints like high device and procedural costs, stringent regulatory approvals, limited number of skilled cardiac surgeons, risks associated with the procedures, and budget constraints in developing regions, which can together suppress the adoption and growth of the market.

 

Market Segmentation

The cardiac valve repair devices market share is classified into position and treatment method.

• The mitral valve devices segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the position, the cardiac valve repair devices market is divided into aortic valve devices, mitral valve devices, and pulmonary & tricuspid valve devices. Among these, the mitral valve devices segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The factors responsible for the global market growth are leading the rise of mitral valve repair market along with the increasing incidence of mitral valve regurgitation and stenosis, growing demand for minimally invasive transcatheter repair procedures, and innovations in the device design, as well as the electronic devices plus surgical and catheter-based interventions' worldwide acceptance.  

 

        

• The transcatheter procedures (TAVR, TMVR) segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the treatment method, the cardiac valve repair devices market is divided into open-heart surgery, minimally invasive surgery, and transcatheter procedures (TAVR, TMVR). Among these, the transcatheter procedures (TAVR, TMVR) segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth due to rising demand for minimally invasive interventions, reduced surgical risks, shorter hospital stays, faster patient recovery, technological advancements in TAVR and TMVR devices, and growing adoption among high-risk and elderly patients, making it the preferred treatment method in the cardiac valve repair market.

 

Regional Segment Analysis of the Cardiac Valve Repair Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the cardiac valve repair devices market over the predicted timeframe.

North America is anticipated to hold the largest share of the cardiac valve repair devices market over the predicted timeframe. The regional growth due to advanced healthcare infrastructure, high adoption of minimally invasive and transcatheter procedures, well-established reimbursement policies, increasing prevalence of cardiovascular diseases, presence of leading device manufacturers, and growing awareness of early diagnosis and treatment options.

 

Asia-Pacific is expected to grow at a rapid CAGR in the cardiac valve repair devices market during the forecast period. The main factors that contributed to this situation include an increase in the number of cardiovascular disease cases, better healthcare facilities, more people choosing less invasive operations, medical tourism getting more popular, government support for new treatments, and patients in developing countries knowing more about the latest techniques.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the cardiac valve repair devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• CryoLife Inc.
• LivaNova PLC
• B. Braun Melsungen AG
• JenaValve Technology, Inc.
• Colibri Heart Valve LLC
• Micro Interventional Devices, Inc.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

• In June?2025, Stony Brook Heart Institute launched a Transcatheter Tricuspid Valve Replacement (TTVR) Program, which offered minimally invasive valve therapy for tricuspid regurgitation and improved treatment access and outcomes for patients on Long Island.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the cardiac valve repair devices market based on the below-mentioned segments: 

 

Global Cardiac Valve Repair Devices Market, By Position

• Aortic Valve Devices
• Mitral Valve Devices
• Pulmonary & Tricuspid Valve Devices

 

Global Cardiac Valve Repair Devices Market, By Treatment Method

• Open-Heart Surgery
• Minimally Invasive Surgery
• Transcatheter Procedures (TAVR, TMVR)

 

Global Cardiac Valve Repair Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the CAGR of the cardiac valve repair devices market over the forecast period?

A: The global Cardiac Valve Repair Devices market is projected to expand at a CAGR of 8.9% during the forecast period.

 

2. What is the cardiac valve repair devices market?

A: The cardiac valve repair devices market consists of various medical devices that are used to treat heart valve disorders by not only repairing or reconstructing the damaged valves but also by improving cardiac function and allowing for both minimally invasive and surgical interventions worldwide.

 

3. Which region holds the largest share of the cardiac valve repair devices market?

A: North America is anticipated to hold the largest share of the cardiac valve repair devices market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global cardiac valve repair devices market?

A: Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, CryoLife Inc., LivaNova PLC, B. Braun Melsungen AG, JenaValve Technology, Inc., Colibri Heart Valve LLC, Micro Interventional Devices, Inc., Others.

 

5. What are the market trends in the cardiac valve repair devices market?

A: The main trends in the cardiac valve repair devices market are the increasing use of less invasive and catheter-based procedures, new developments in biomaterials and imaging technologies, population aging, and improved healthcare infrastructure in developing areas.